CTIS2024-515398-90-01进行中（未招募）1 期
SAFE study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Adults with methicillin-sensitive complicated SAB, defined as having at least one blood culture positive for S. aureus and one of the following conditions:, Evidence of organ involvement and/or deep-seated infection. Examples of clinical diagnoses are: endocarditis, spondylodiscitis, arthritis, intravascular infection, abscess, and/or metastatic complications., Predictors of complicated SAB, defined as presence of at least one of the following risk factors for complicated SAB: a. community acquisition; b. delay > 48 hours of adequate treatment after the initial positive blood culture; c. positive follow-up blood culture > 48 hours after initiation of adequate treatment; d. persistence of fever at 72 hours after the initial positive blood culture (temperature > 38 degrees for two consecutive calendar days, measured at two time points with at least 24 hours interval, between 2 days and 7 days after the initial positive blood culture) e.unknown primary source of infection (porte d’entrée)., 1)Satisfactory clinical response to initial treatment, defined as meeting all of the following: a)Negative blood culture for S. aureus on day 8 of adequate antibiotic treatment, defined as intravenous administration of an antibiotic agent with in-vitro activity against the cultured S. aureus. In absence of blood culture sampling on day 8, the date of first negative blood culture is the midpoint between the last positive blood culture for S. aureus and the first negative blood culture for S. aureus. b)Negative intra-operative cultures in patients with S. aureus native valve endocarditis who underwent cardiac surgery. c)C-reactive protein (CRP) decline to at least 50% below peak level or to <30 mg/L within 14 days of adequate antibiotic treatment. A high CRP due to an evident other cause, for example, an unrelated infection, is disregarded in this definition. d)Absence of fever (temperature < 38 degrees for two consecutive calendar days, measured at two time points with at least 24 hours interval) between 7 and 14 days of adequate antibiotic treatment. Fever due to unrelated, intercurrent infection (e.g. respiratory tract infection) is disregarded in this definition.
排除标准
- •Infected prosthetic heart valve or other infected prosthetic material which is not removed within 14 days of antibiotic therapy, as manifested by either one of the following: a)Clinical suspicion of infected prosthetic material; b)Transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE) positive for prosthetic valve or device endocarditis; c)Positron emission tomography/computed tomography (PET/CT) scan positive for infection of prosthetic material (including prosthetic heart valve, cardiac device, vascular prosthesis or joint prosthesis)., Presence of undrained abscess of 5 cm or more in one direction on radiological imaging at day 14 of antibiotic treatment ., Pregnancy or lactation.
研究者
相似试验
尚未招募
不适用
An observational study investigating the safety, tolerability and health outcomes of cannabinoid therapy prescribed to eligible patients for management of recognized chronic conditionsAny recognized condition for which medicinal cannabis could be prescribed forChronic PainMood DisorderParkinson's disease/TremorSeizure management/EpilepsyNeuropathic painInflammatory bowel disease/Irritable bowel syndromeChemotherapy-induced nausea and vomitingAnaesthesiology - Pain managementMental Health - AnxietyNeurological - EpilepsyMental Health - Other mental health disordersNeurological - Parkinson's diseaseNeurological - Other neurological disordersCancer - Any cancerDementiaInsomniaPost-traumatic stress disorderAnxietyAutismACTRN12623000149662Cloud Medical PTY LTD2,000
进行中（未招募）
不适用
Prospective study to demonstrate safety and usability as well as a positive healthcare effect in the domestic use of the PleurX Drainage Minikit for the drainage of pleural effusions and ascitesJ90R18Pleural effusion, not elsewhere classifiedAscitesDRKS00029116Becton Dickinson7
已完成
不适用
A randomised controlled trial to evaluate SAFE® - Basic Trust, an intervention to support attachment security and parental mentalizatioO00-O99F00-F99Pregnancy, childbirth and the puerperiumMental and behavioural disordersDRKS00013099Paracelsus Medizinische Privatuniversität Salzburg, Insitut für Early Life Care135
招募中
1 期
Polylaminin for Acute Spinal Cord Injurynspecified injury at unspecified level of cervical spinal cordUnspecified injury at unspecified level of thoracic spinal cordG00-G99RBR-9dfvgpmniversidade Federal do Rio de Janeiro
进行中（未招募）
1 期
A prospective, randomised study to access safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in antiretroviral therapy. - The St. Marys and The Mater Switch Study (SMASH)HIVEUCTR2009-011538-93-IEImperial College London40